These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26304253)

  • 21. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist.
    Berekashvili K; Zha AM; Abdel-Al M; Zhang X; Soomro JH; Prater SJ; Grotta JC
    Stroke; 2020 Feb; 51(2):663-665. PubMed ID: 31771461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. tPA in daily clinical practice.
    Nighoghossian N
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12733503
    [No Abstract]   [Full Text] [Related]  

  • 24. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
    Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
    Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
    Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neck hematoma after intravenous thrombolysis for stroke treatment.
    Fonseca AC; Geraldes R; Reimão S; Pinho e Melo T; Ferro JM
    Cerebrovasc Dis; 2010; 30(1):101-2. PubMed ID: 20501994
    [No Abstract]   [Full Text] [Related]  

  • 28. Myocardial Infarction Following Intravenous Thrombolysis for Acute Ischemic Stroke: Case Report and Literature Review.
    Mannino M; Asciutto S; Terruso V; Gammino M; Cellura MG; Monaco S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e105-e107. PubMed ID: 28434774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of acute ischemic stroke: time is brain.
    Rymner MM; Akhtar N; Martin C; Summers D
    Mo Med; 2010; 107(5):333-7. PubMed ID: 21207786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous thrombolysis in patients older than age 80 years.
    Longstreth WT; Tirschwell DL
    Stroke; 2010 Oct; 41(10):e580; author reply e581. PubMed ID: 20798362
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 32. Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?
    Strbian D; Saposnik G
    Stroke; 2016 Dec; 47(12):3063-3064. PubMed ID: 27789665
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.
    Fugate JE; Rabinstein AA
    Mayo Clin Proc; 2014 Jul; 89(7):960-72. PubMed ID: 24775222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid meningitis presenting with a stroke-like attack treated with recombinant tissue plasminogen activator: a case presentation.
    Akamatsu M; Maki F; Akiyama H; Hara D; Hoshino M; Hasegawa Y
    BMC Neurol; 2018 Sep; 18(1):139. PubMed ID: 30189853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP
    Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan.
    Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS
    Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of intravenous tissue plasminogen activator in a pediatric patient with acute ischemic stroke.
    Shuayto MI; Lopez JI; Greiner F
    J Child Neurol; 2006 Jul; 21(7):604-6. PubMed ID: 16970853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke Mimics and Acute Stroke Evaluation: Clinical Differentiation and Complications after Intravenous Tissue Plasminogen Activator.
    Nguyen PL; Chang JJ
    J Emerg Med; 2015 Aug; 49(2):244-52. PubMed ID: 25802155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.